Skip to Content

Agilent Technologies Inc

A: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$822.00XxzPjkrjztsd

Near-Term Biopharma Uncertainty Does Not Change Agilent's Long-Term Prospects

Business Strategy and Outlook

After Agilent was spun out from Hewlett Packard in 1999 and divested its electronic measurement business (Keysight Technologies) in November 2014, Agilent focuses on providing tools to analyze the structural properties of various chemicals, molecules, and cells. Agilent is one of the leading providers of chromatography and mass spectrometry tools, which have applications in a variety of end markets, including the healthcare, chemical, food, and environmental fields. While healthcare-related applications, including clinical diagnostics, remain Agilent’s largest end market, Agilent generates about half of its sales from nonhealthcare fields.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of A so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center